Dow Up 0.44% Nasdaq Down 0.00%

More On VTUS

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Ventrus Biosciences Inc. (VTUS)

-NasdaqCM
1.45 Up 0.01(0.69%) Jul 11 - Nasdaq Real Time Price
Prev Close:1.45
Open:1.45
Bid:N/A
Ask:N/A
1y Target Est:6.50
Beta:-0.08
Next Earnings Date:N/A
Day's Range:1.39 - 1.46
52wk Range:0.85 - 4.69
Volume:219,742
Avg Vol (3m):712,684
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.31
Quarterly EPS Est (Sep-14) :-0.49
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-0.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ventrus Biosciences, Inc., a development-stage specialty pharmaceutical company, focuses on the late-stage development and commercialization of gastrointestinal products in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback